Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05467891
Title Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oana Danciu
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.